International consensus for a definition of disease flare in lupus

Lupus

Volumn 20, Issue 5, 2011, Pages 453-462

  Ruperto, N ^a   Hanrahan, L M ^b   Alarcon G S ^c   Belmont, H M ^d   Brey, R L ^e   Brunetta, P ^f   Buyon, J P ^g   Costner, M I ^h   Cronin, M E ⁱ   Dooley, M A ^j   Filocamo, G ^a   Fiorentino, D ^k   Fortin, P R ^l   Franks, A G ^g   Gilkeson, G ^m   Ginzler, E ⁿ   Gordon, C ^o   Grossman, J ^p   Hahn, B ^p   Isenberg, D A ^q   Kalunian, K C ^r   Petri, M ^s   Sammaritano, L ^t   Sanchez Guerrero J ^u   Sontheimer, R D ^v   Strand, V ^k   Urowitz, M ^l   Von Feldt, J M ^w   Werth, V P ^w,x   Merrill, J T ^y   more..

^a Reumatologia   (Italy)

^b Lupus Foundation of America Inc   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d NYU HOSPITAL FOR JOINT DISEASES   (United States)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^f GENENTECH INC   (United States)

^g NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

ⁱ MEDICAL COLLEGE OF WISCONSIN   (United States)

^j UNIVERSITY OF NORTH CAROLINA   (United States)

^k STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l UNIVERSITY OF TORONTO   (Canada)

^m MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

ⁿ SUNY DOWNSTATE MEDICAL CENTER   (United States)

^o UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^p UNIVERSITY OF CALIFORNIA   (United States)

^q UNIVERSITY COLLEGE LONDON   (United Kingdom)

^r UNIVERSITY OF CALIFORNIA   (United States)

^s DEPARTMENT OF PATHOLOGY   (United States)

^t HOSPITAL FOR SPECIAL SURGERY   (United States)

^u INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^v UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^w UNIVERSITY OF PENNSYLVANIA   (United States)

^x VETERANS AFFAIRS MEDICAL CENTER   (United States)

^y OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

more..

Author keywords

autoimmune disease; flare; systemic lupus erythematosus

Indexed keywords

ARTICLE; CLINICAL FEATURE; CONSENSUS; CONSENSUS DEVELOPMENT; DELPHI STUDY; DISEASE ACTIVITY; DISEASE EXACERBATION; HEALTH CARE ORGANIZATION; HUMAN; LABORATORY TEST; NOMENCLATURE; NORMAL HUMAN; PHYSICIAN; PRIORITY JOURNAL; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ACUTE DISEASE; DELPHI TECHNIQUE; HUMANS; INTERNATIONALITY; LUPUS ERYTHEMATOSUS, SYSTEMIC; TERMINOLOGY AS TOPIC;

EID: 79955664608     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203310388445     Document Type: Article

References (25)

1. Ter Borg EJ, Horst G, Hummel EJ, Limburg PC, Kallenberg CG. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study. Arthritis Rheum. 1990 ; 33: 634-643 (Pubitemid 20166564)
2. Bootsma H, Spronk PE, Ter Borg EJ, et al. The predictive value of fluctuations in IgM and IgG class anti-dsDNA antibodies for relapses in systemic lupus erythematosus. A prospective long-term observation. Ann Rheum Dis. 1997 ; 56: 661-666 (Pubitemid 28007923)
3. Petri M, Genovese M, Engle E, Hochberg M. Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study. Arthritis Rheum. 1991 ; 34: 937-944
4. Gladman D, Urowitz M, Fortin P, et al. Systemic Lupus International Collaborating Clinics conference on assessment of lupus flare and quality of life measures in SLE. J Rheumatol. 1996 ; 23: 1953-1955 (Pubitemid 26376123)
5. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992 ; 35: 630-640
6. Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum. 1989 ; 32: 1107-1118 (Pubitemid 19237865)
7. Vitali C, Bencivelli W, Isenberg DA, et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. Clin Exp Rheumatol. 1992 ; 10: 541-547
8. Vitali C, Bencivelli W, Mosca M, Carrai P, Sereni M, Bombardieri S. Development of a clinical chart to compute different disease activity indices for systemic lupus erythematosus. J Rheumatol. 1999 ; 26: 498-501 (Pubitemid 29066764)
9. Hay EM, Bacon PA, Gordon C, et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med. 1993 ; 86: 447-458 (Pubitemid 23223653)
10. Petri M, Kim MY, Kalunian KC, et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med. 2005 ; 353: 2550-2558 (Pubitemid 41785892)
11. Albrecht J, Taylor L, Berlin JA, et al. The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus. J Invest Dermatol. 2005 ; 125: 889-894
12. Buyon JP, Petri MA, Kim MY, et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med. 2005 ; 142: 953-962
13. Ruperto N, Martini A. International research networks in pediatric rheumatology: the PRINTO perspective. Curr Opin Rheumatol. 2004 ; 16: 566-570 (Pubitemid 39128326)
14. Sniderman AD. Clinical trials, consensus conferences, and clinical practice. Lancet. 1999 ; 354: 327-330 (Pubitemid 29348753)
15. Felson DT, Anderson JJ, Boers M, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum. 1993 ; 36: 729-740 (Pubitemid 23175613)
16. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Martini A,. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum. 1996 ; 39 (9 Suppl). S56 - S56
17. Wallace CA, Ruperto N, Giannini E, et al. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol. 2004 ; 31: 2290-2294 (Pubitemid 39453253)
18. Ruperto N, Ravelli A, Murray KJ, et al. Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Rheumatology (Oxford). 2003 ; 42: 1452-1459 (Pubitemid 37508918)
19. Ruperto N, Ravelli A, Cuttica R, et al. The Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the disease activity core set. Arthritis Rheum. 2005 ; 52: 2854-2864 (Pubitemid 41369116)
20. Ruperto N, Ravelli A, Oliveira S, et al. The Pediatric Rheumatology International Trials Organization/American College of Rheumatology provisional criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus. Prospective validation of the definition of improvement. Arthritis Rheum. 2006 ; 55: 355-363 (Pubitemid 43887020)
21. Ruperto N, Ravelli A, Pistorio A, et al. The provisional Pediatric Rheumatology International Trial Organization/American College of Rheumatology/European League Against Rheumatism disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study. Arthritis Rheum. 2008 ; 59: 4-13 (Pubitemid 351171873)
22. Miller FW, Rider LG, Chung YL, et al. Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology. 2001 ; 40: 1262-1273
23. Rider LG, Giannini EH, Brunner HI, et al. International consensus on preliminary definitions of improvement in adult and juvenile myositis. Arthritis Rheum. 2004 ; 50: 2281-2290 (Pubitemid 38924407)
24. Oddis CV, Rider LG, Reed AM, et al. International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies. Arthritis Rheum. 2005 ; 52: 2607-2615 (Pubitemid 41369088)
25. Gordon C, Sutcliffe N, Skan J, Stoll T, Isenberg DA. Definition and treatment of lupus flares measured by the BILAG index. Rheumatology. 2003 ; 42: 1372-1379 (Pubitemid 37407029)